Medscape Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 71.43%
(FY 2023)
- Profit 5667.03%
(FY 2023)
- Ebitda 7988.92%
(FY 2023)
- Net Worth 1048.18%
(FY 2023)
- Total Assets 22.18%
(FY 2023)
About Medscape Pharma
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narayana Panicker and Chaniyilparampu Ramchand serve as directors at the Company.
- CIN/LLPIN
U24290TN2021PTC143874
- Company No.
143874
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medscape Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayana Panicker  | Director | 02-Jun-2021 | Current |
Chaniyilparampu Ramchand  | Director | 02-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Medscape Pharma.
Medscape Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.43% increase. The company also saw a substantial improvement in profitability, with a 5667.03% increase in profit. The company's net worth Soared by an impressive increase of 1048.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medscape Pharma?
Unlock access to Medscape Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Maggenome Technologies Private LimitedActive 9 years 6 monthsChaniyilparampu Ramchand is a mutual person
Secureinteli Technologies Private LimitedActive 10 years 6 monthsNarayana Panicker is a mutual person
Theragen Biologics Private LimitedActive 16 years 10 monthsChaniyilparampu Ramchand is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medscape Pharma?
Unlock and access historical data on people associated with Medscape Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medscape Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medscape Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
